See more : Mufin Green Finance Limited (MUFIN.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Research Solutions, Inc. (RSSS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Research Solutions, Inc., a leading company in the Software – Application industry within the Technology sector.
You may be interested
- PPAP Automotive Limited (PPAP.BO) Income Statement Analysis – Financial Results
- ClimateRock (CLRCR) Income Statement Analysis – Financial Results
- THC Biomed Intl Ltd. (THC.CN) Income Statement Analysis – Financial Results
- HPX Corp. (HPX) Income Statement Analysis – Financial Results
- Virgin Orbit Holdings, Inc. (VORBW) Income Statement Analysis – Financial Results
Research Solutions, Inc. (RSSS)
About Research Solutions, Inc.
Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was founded in 2006 and is based in Henderson, Nevada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.62M | 37.70M | 32.93M | 31.76M | 31.06M | 28.79M | 28.02M | 25.75M | 34.36M | 31.90M | 36.55M | 45.50M | 42.82M | 33.50M | 24.94M | 14.65M | 12.21M | 3.85M |
| Cost of Revenue | 24.98M | 23.00M | 20.91M | 21.47M | 21.42M | 20.45M | 20.67M | 19.64M | 27.86M | 25.72M | 28.20M | 35.95M | 34.78M | 29.59M | 21.02M | 11.41M | 10.02M | 3.25M |
| Gross Profit | 19.64M | 14.70M | 12.02M | 10.29M | 9.64M | 8.34M | 7.35M | 6.10M | 6.50M | 6.18M | 8.35M | 9.55M | 8.04M | 3.91M | 3.92M | 3.24M | 2.19M | 597.63K |
| Gross Profit Ratio | 44.01% | 38.99% | 36.50% | 32.39% | 31.03% | 28.98% | 26.23% | 23.71% | 18.92% | 19.36% | 22.83% | 20.99% | 18.78% | 11.66% | 15.71% | 22.11% | 17.90% | 15.52% |
| Research & Development | 5.44M | 3.74M | 3.71M | 2.64M | 2.12M | 2.14M | 1.80M | 1.48M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 10.67M | 8.50M | 7.50M | 5.88M | 5.82M | 5.32M | 5.18M | 5.65M | 6.83M | 6.40M | 9.62M | 9.07M | 0.00 | 7.87M | 3.59M | 4.02M | 2.17M | 981.12K |
| Selling & Marketing | 3.44M | 2.29M | 2.28M | 2.07M | 2.51M | 2.08M | 2.18M | 3.39M | 5.29K | 0.00 | 0.00 | 0.00 | 0.00 | 618.98K | 439.88K | 158.52K | 40.44K | 23.66K |
| SG&A | 14.11M | 14.41M | 9.78M | 7.95M | 8.32M | 7.40M | 7.36M | 9.03M | 6.83M | 6.40M | 9.62M | 9.07M | 10.72M | 8.49M | 4.03M | 4.18M | 2.21M | 1.00M |
| Other Expenses | 857.67K | 338.62K | 17.65K | 11.52K | 23.65K | 38.82K | 58.18K | 23.86K | -31.61K | 1.22K | -15.56K | -84.02K | 3.97M | 673.88K | 206.62K | 235.66K | 341.47K | 0.00 |
| Operating Expenses | 20.41M | 14.46M | 13.51M | 10.61M | 10.47M | 9.57M | 9.31M | 9.17M | 6.92M | 6.57M | 10.13M | 9.66M | 12.18M | 9.16M | 4.24M | 4.41M | 2.55M | 1.10M |
| Cost & Expenses | 45.39M | 37.46M | 34.42M | 32.08M | 31.89M | 30.02M | 29.98M | 28.81M | 34.78M | 32.30M | 38.33M | 45.61M | 46.96M | 38.76M | 25.26M | 15.83M | 12.58M | 4.35M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.38K | 3.23K | 4.17K | 39.53K | 111.34K | 88.49K |
| Interest Expense | 0.00 | 0.00 | 136.74K | 0.00 | 0.00 | 0.00 | 4.00K | 12.00K | 17.38K | 18.06K | 55.92K | 89.41K | 220.67K | 144.07K | 6.92K | 34.99K | 32.31K | 6.35K |
| Depreciation & Amortization | 836.27K | 52.65K | 17.65K | 83.85K | 143.57K | 153.90K | 262.99K | 133.69K | 90.85K | 174.82K | 507.68K | 617.90K | 1.53M | 750.19K | 270.98K | 283.58K | 278.49K | 44.18K |
| EBITDA | 66.73K | 291.26K | -1.47M | -235.14K | -628.28K | -1.08M | -1.63M | -2.93M | -1.23M | -318.42K | -834.28K | 897.56K | -5.10M | -4.51M | -40.61K | -684.37K | -17.02K | -443.63K |
| EBITDA Ratio | 0.15% | 0.77% | -4.03% | -0.85% | -2.15% | -3.37% | -5.84% | -11.11% | -1.05% | -0.69% | -3.52% | 0.92% | -6.09% | -13.44% | -0.18% | -5.78% | -0.46% | -11.52% |
| Operating Income | -769.54K | 238.61K | -1.49M | -318.99K | -832.37K | -1.23M | -1.95M | -3.08M | -420.70K | -494.45K | -1.78M | 363.69K | -6.65M | -5.26M | -321.18K | -1.17M | -367.81K | -502.62K |
| Operating Income Ratio | -1.72% | 0.63% | -4.52% | -1.00% | -2.68% | -4.27% | -6.96% | -11.98% | -1.22% | -1.55% | -4.87% | 0.80% | -15.54% | -15.69% | -1.29% | -8.01% | -3.01% | -13.05% |
| Total Other Income/Expenses | -2.90M | 338.62K | 7.15K | 1.15K | 80.04K | 107.31K | 54.18K | 11.86K | -48.99K | -16.84K | -13.05K | -173.43K | -202.02K | -150.72K | 2.67K | 136.81K | 29.49K | 82.14K |
| Income Before Tax | -3.67M | 577.23K | -1.62M | -281.89K | -771.85K | -1.15M | -1.90M | -3.07M | -469.70K | -511.29K | -1.85M | 190.25K | -6.85M | -5.41M | -318.51K | -1.03M | -401.47K | 0.00 |
| Income Before Tax Ratio | -8.23% | 1.53% | -4.93% | -0.89% | -2.49% | -3.99% | -6.77% | -11.93% | -1.37% | -1.60% | -5.06% | 0.42% | -16.01% | -16.14% | -1.28% | -7.06% | -3.29% | 0.00% |
| Income Tax Expense | 113.07K | 5.60K | 7.62K | 3.20K | 7.84K | 27.04K | 39.78K | 35.50K | 28.16K | 30.89K | 16.10K | -1.67K | -322.11K | 144.07K | 1.13K | 32.17K | -29.49K | -72.32K |
| Net Income | -3.79M | 571.62K | -1.63M | -285.09K | -779.69K | -1.17M | -1.68M | -2.29M | -497.86K | 774.22K | -1.87M | 191.92K | -6.53M | -5.41M | -307.19K | -1.07M | -338.32K | -415.49K |
| Net Income Ratio | -8.49% | 1.52% | -4.96% | -0.90% | -2.51% | -4.08% | -5.99% | -8.91% | -1.45% | 2.43% | -5.11% | 0.42% | -15.26% | -16.14% | -1.23% | -7.28% | -2.77% | -10.79% |
| EPS | -0.13 | 0.02 | -0.06 | -0.01 | -0.03 | -0.05 | -0.07 | -0.10 | -0.03 | 0.04 | -0.11 | 0.01 | -0.38 | -0.36 | -0.02 | -0.08 | -0.03 | -0.04 |
| EPS Diluted | -0.13 | 0.02 | -0.06 | -0.01 | -0.03 | -0.05 | -0.07 | -0.10 | -0.03 | 0.04 | -0.11 | 0.01 | -0.38 | -0.36 | -0.02 | -0.08 | -0.03 | -0.04 |
| Weighted Avg Shares Out | 28.86M | 26.86M | 26.42M | 26.01M | 24.76M | 23.82M | 23.47M | 23.24M | 17.05M | 17.45M | 17.23M | 17.12M | 17.05M | 14.96M | 12.97M | 12.95M | 12.54M | 10.63M |
| Weighted Avg Shares Out (Dil) | 28.86M | 29.14M | 26.42M | 26.01M | 24.76M | 23.82M | 23.47M | 23.24M | 17.77M | 17.96M | 17.23M | 17.26M | 17.05M | 14.96M | 12.97M | 12.95M | 12.54M | 10.63M |
Research Solutions to Announce Third Quarter Fiscal 2024 Results on Thursday, May 9, 2024
HENDERSON, Nev. , April 30, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 third quarter...
Alchemer Research Solutions Expands Customers' Market Research Capabilities, with Best-in-Class Speed, Reach, and Analysis
LOUISVILLE, Colo.--(BUSINESS WIRE)--Alchemer, a global leader in experience management and enterprise feedback technology, today announced the launch of Alchemer Research Solutions, a full-service market research team available to help customers quickly expand and scale their research capabilities to ensure they...
Research Solutions Unveils AI Platform for Automated Clinical Trial Landscape Reports
Powerful AI, combined with comprehensive data, simplifies the discovery and synthesis of clinical trial information to accelerate innovation in the medical field HENDERSON, Nev. , April 15, 2024 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to...
Heart Rhythm Clinical and Research Solutions and the Real World Evidence Consortium Launch EVERCOOL AF Study on Attune Medical's ensoETM®
CHICAGO--(BUSINESS WIRE)--Heart Rhythm Clinical and Research Solutions (HRCRS) and the Real World Evidence (RWE) Consortium have enrolled the first patient in the REView of ProcEdural FactoRs and Outcomes after Atrial Fibrillation Ablation with Active Esophageal COOLing (EVERCOOL AF) study. The...
3 Millionaire-Maker AI Stocks to Buy Before Wall Street Does
Nvidia's (NASDAQ: NVDA ) recent AI conference showcased some impressive new technology, including the company's expensive new AI chip that purportedly outperforms all other AI chips on the market. However, the hype did not translate into a meaningful stock price...
Has Research Solutions (RSSS) Outpaced Other Industrial Products Stocks This Year?
Here is how Research Solutions Inc. (RSSS) and AB SKF (SKFRY) have performed compared to their sector so far this year.
Research Solutions Launches AI Platform to Automatically Create Technology Landscape Reports
AI-powered software module enables production of reports in minutes to save months of manual analysis HENDERSON, Nev. , Feb. 15, 2024 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, today...
Research Solutions, Inc. (RSSS) Q2 2024 Earnings Call Transcript
Research Solutions, Inc. (RSSS) Q2 2024 Earnings Call Transcript
Research Solutions Reports Fiscal Second Quarter 2024 Results
Reports 18.3% Revenue Increase and ARR of $15.6 Million HENDERSON, Nev. , Feb. 8, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a trusted partner providing cloud-based workflow solutions to accelerate research for R&D-driven organizations, reported financial results for its...
Research Solutions to Announce Second Quarter Fiscal 2024 Results on Thursday, February 8, 2024
HENDERSON, Nev. , Jan. 31, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 second quarter...
Source: https://incomestatements.info
Category: Stock Reports